Do patients with major depressive disorder and generalized anxiety disorder experience more somatosensorial amplification, hypochondriasis, and fear of COVID-19?

ÖZDAMAR ÜNAL, Gülin; DEMİRAY, Kadriye; ÜNAL, Onur

doi:10.14744/dajpns.2022.00169

Do patients with major depressive disorder and generalized anxiety disorder experience more somatosensorial amplification, hypochondriasis, and fear of COVID-19?

ÖZDAMAR ÜNAL G. , DEMİRAY K. E. , ÜNAL O.

DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, vol.35, no.1, pp.34-42, 2022 (Journal Indexed in ESCI)

Publication Type: Article / Article
Volume: 35 Issue: 1
Publication Date: 2022
Doi Number: 10.14744/dajpns.2022.00169
Title of Journal : DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES
Page Numbers: pp.34-42
Keywords: Anxiety, COVID-19, depression, hypochondriasis, somatosensorial amplification, MENTAL-HEALTH, SOMATIZATION, POPULATION, SYMPTOMS, LOCKDOWN, PEOPLE, IMPACT, SCALE

Abstract

Objective: Mental illnesses are important determinants in response to the pandemic. However, there are only a limited number of studies investigating the effects of COVID-19 in individuals with mental illnesses. We aimed to reveal the fear of COVID-19, somatosensorial amplification levels, anxiety, depression, and stress levels of patients with major depressive disorder (MDD) and generalized anxiety disorder (GAD).